Runyan, House Colleagues Demand Better Prostate Cancer Treatment For Vets
WASHINGTON, DC - Soldiers, seniors and low income patients with late-stage prostate cancer all have access to the same high-powered drug treatment approved by the Federal Drug Administration. But not veterans. Shore Representative Jon Runyan (R-NJ) and a bipartisan group in the House is urging the Department of Veterans Affairs to grant access to Provenge.